SEARCH

SEARCH BY CITATION

References

  • Berenbaum, M. C., Bonnett, R., Chevretton, E. B., Akande-Adebakin, S. L. and Ruston, M., Selectivity of meso-tetra(Hydroxyphenyl)porphyrins and chlorins and of Photofrin II in causing photodamage in tumour, skin, muscle, and bladder. The concept of cost benefit in analysing the results. Lasers Med. Sci., 8, 235234 (1993).
  • Bonnett, R., Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev., 24, 1933 (1995).
  • Day, G. and Blot, W. J., Second primary tumors in patients with oral cancer. Cancer, 70, 1419 (1992).
  • Dilkes, M. G., De Jode, M. L., Gardiner, Q., Keynon, G. S. and McKelvie, P., Treatment of head and neck cancer with photodynamic therapy: results after one year. J. Laryngol. Otol., 109, 10721076 (1995).
  • Fan, K. F., Hopper, C., Speight, P., Buonaccorsi, G., MacRobert, A. and Bown, S., Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer, 78, 137483 (1996).
  • Foote, C. S., Chemical mechanisms of photodynamic action, Proc. SPIE Institute Advanced Optical Technologies on Photodynamic Therapy IS. Vol. 6, pp. 115126 (1990).
  • Fuller, D., Speech and swallowing rehabilitation for head and neck tumour patients. In: S. E.Thawley and W. R.Panje (eds.), Comprehensive Management of Head and Neck Tumours, pp. 10031, Saunders, Philadelphia (1987).
  • Gibson, S. L., van der Meid, K. R., Murant, R. S., Raubertas, R. F. and Hilf, R., Effects of various photoirradiation regimens on the antitumour efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res., 50, 72367241 (1990).
  • Grant, W. E., Hopper, C., MacRobert, A. J., Speight, P. M. and Bown, S. G., Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet, 342, 1478 (1993a).
  • Grant, W. E., Hopper, C., Speight, P. M., MacRobert, A. J. and Bown, S. G., Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity. J. Laryngol Otol., 107, 11401145 (1993b).
  • Jovanoic, A., van der Tol, I. G. H., Kostense, P. J., Schulten, E. A. J. M., Snow, G. B. and van der Waal, I., Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma. Oral Oncol. Europ. J. Cancer, 30B, 225220 (1994).
  • Lippman, S. M., Benner, S. E. and Hong, W. K., Cancer chemoprevention. J. clin. Oncol., 12, 851873 (1994).
  • Messmann, H., Mlkvy, P., Buonaccorsi, G., Davies, C. L., MacRobert, A. J. and Bown, S. G., Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Brit. J. Cancer, 72, 58994 (1995).
  • Parkin, D. M., Pisani, P. and Ferlay, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594606 (1993).
  • Regula, J., MacRobert, A. J., Gorchein, A., Buonaccorsi, G. A., Thorpe, S. M., Spencer, G. M., Hatfield, A. R. and Bown, S. G., Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX: a pilot study. Gut, 36, 6775 (1995).
  • Ris, H. B., Altermatt, H. J., Inderbitzi, R., Hess, R., Nachbur, B., Stewart, J. C., Wang, Q., Lim, C. K., Bonnett, R., Berenbaum, M. C. and et al., Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Brit. J. Cancer, 64, 111620 (1991).
  • Savary, J.-F., Monnier, P., Wagniéres, G., Fontolliet, C. and van den Bergh, H., Preliminary clinical studies of photodynamic therapy with meso-tetrahydroxyphenylchlorin (mTHPC) as a photosensitizing agent for the treatment of early pharyngeal, oesophageal and bronchial carcinomas. Proc. Soc. Photo-Opt. Instr. Eng., 2078, 330340 (1993).
  • Slaughter, P. D., Southwick, H. W. and Smejkal, W., ‘Field cancerization’ in oral stratified squamous epithelium. Cancer, 6, 963968 (1953).
  • van der Veen, N., van Leengoed, H. and Star, W. M., In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Brit. J. Cancer, 70, 86772 (1994).
  • Warren, S. and Gates, O., Multiple primary malignant tumors: a survey of the literature and statistical study. Amer. J. Cancer, 51, 13581403 (1932).
  • Wenig, B. L., Kurtzman, D. M., Grossweiner, L. I., Mafee, M. F., Harris, D. M., Lobraico, R. V., Prycz, R. A. and Appelbaum, E. L., Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 116, 126770 (1990).
  • Zakrzewska, J., Lopes, V., Speight, P. and Hopper, C., Proliferative verrucous leukoplakia: a report of ten patients supporting this diagnosis. Oral Surg. Oral Med. Oral Pathol., 82, 396401 (1996).